Bristol Myers Squibb to Report Results for First Quarter 2025 on April 24, 2025
PRINCETON, N.J.--(BUSINESS WIRE)--March 13, 2025--
Bristol Myers Squibb $(BMY)$ will announce results for the first quarter of 2025 on Thursday, April 24, 2025. Company executives will review financial results with the investment community during a conference call beginning at 8:00 a.m. ET.
Investors and the general public are invited to listen to a live webcast of the call at http://investor.bms.com. Materials related to the call will be available at http://investor.bms.com prior to the start of the conference call.
A replay of the webcast will be available at http://investor.bms.com approximately three hours after the conference call concludes.
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, X, YouTube, Facebook and Instagram.
corporatefinancial-news
View source version on businesswire.com: https://www.businesswire.com/news/home/20250313006466/en/
CONTACT: Media Relations:
media@bms.com
Investor Relations:
investor.relations@bms.com
(END) Dow Jones Newswires
March 13, 2025 07:11 ET (11:11 GMT)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.